APO Research
Talk to an analyst

APO RESEARCH · REPORT

Valsartan-Hydrochlorothiazide

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Valsartan-Hydrochlorothiazide Market Outlook and Growth Opportunities 2026

20 December 2025190 pages

Choose your research edition.

Industry ResearchValsartan-Hydrochlorothiazide Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Valsartan-Hydrochlorothiazide Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Valsartan-Hydrochlorothiazide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Valsartan-Hydrochlorothiazide Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Valsartan-Hydrochlorothiazide Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Valsartan-Hydrochlorothiazide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Valsartan-Hydrochlorothiazide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Valsartan-Hydrochlorothiazide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Valsartan-Hydrochlorothiazide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Valsartan-Hydrochlorothiazide market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Valsartan-Hydrochlorothiazide market include Teva, Novartis, Mylan, Huaren Pharmaceutical, Zhejiang Huahai Pharmaceutical, Torrent Pharmaceuticals, Par Pharmaceutical, MACLEODS and Lupin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Valsartan-Hydrochlorothiazide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Valsartan-Hydrochlorothiazide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Valsartan-Hydrochlorothiazide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Valsartan-Hydrochlorothiazide market size, projected growth trends, production technologies, key applications, and end-use industries.

Valsartan-Hydrochlorothiazide Segment by Company

Teva

Novartis

Mylan

Huaren Pharmaceutical

Zhejiang Huahai Pharmaceutical

Torrent Pharmaceuticals

Par Pharmaceutical

MACLEODS

Lupin

Cisen Pharmaceutical

Chongqing Conquer Pharmaceutical

Beijing Second Pharmaceutical

Aurobindo Pharma

APOTEX

Alembic Pharmaceuticals

Valsartan-Hydrochlorothiazide Segment by Type

Tablet

Capsule

Valsartan-Hydrochlorothiazide Segment by Application

Hospital

Drug Store

Valsartan-Hydrochlorothiazide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Valsartan-Hydrochlorothiazide status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Valsartan-Hydrochlorothiazide market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Valsartan-Hydrochlorothiazide significant trends, drivers, influence factors in global and regions.

6. To analyze Valsartan-Hydrochlorothiazide competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valsartan-Hydrochlorothiazide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Valsartan-Hydrochlorothiazide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valsartan-Hydrochlorothiazide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Valsartan-Hydrochlorothiazide market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Valsartan-Hydrochlorothiazide industry.

Chapter 3: Detailed analysis of Valsartan-Hydrochlorothiazide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Valsartan-Hydrochlorothiazide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Valsartan-Hydrochlorothiazide in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Valsartan-Hydrochlorothiazide Industry Trends Table 2. Valsartan-Hydrochlorothiazide Industry Drivers Table 3. Valsartan-Hydrochlorothiazide Industry Opportunities and Challenges Table 4. Valsartan-Hydrochlorothiazide Industry Restraints Table 5. Global Valsartan-Hydrochlorothiazide Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Valsartan-Hydrochlorothiazide Revenue Share by Company (2021-2026) Table 7. Global Valsartan-Hydrochlorothiazide Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Valsartan-Hydrochlorothiazide Sales Volume Share by Company (2021-2026) Table 9. Global Valsartan-Hydrochlorothiazide Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Valsartan-Hydrochlorothiazide Company Ranking, (2024-2026) & (USD Million) Table 11. Global Valsartan-Hydrochlorothiazide Key Company Manufacturing Base & Headquarters Table 12. Global Valsartan-Hydrochlorothiazide Company, Product Type & Application Table 13. Global Valsartan-Hydrochlorothiazide Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Valsartan-Hydrochlorothiazide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablet Table 18. Significant Companies of Capsule Table 19. Global Valsartan-Hydrochlorothiazide Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Valsartan-Hydrochlorothiazide Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Valsartan-Hydrochlorothiazide Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Valsartan-Hydrochlorothiazide Sales Volume Share by Type (2021-2026) Table 23. Global Valsartan-Hydrochlorothiazide Sales Volume Share by Type (2027-2032) Table 24. Global Valsartan-Hydrochlorothiazide Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Valsartan-Hydrochlorothiazide Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Valsartan-Hydrochlorothiazide Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Valsartan-Hydrochlorothiazide Sales Value Share by Type (2021-2026) Table 28. Global Valsartan-Hydrochlorothiazide Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Drug Store Table 31. Global Valsartan-Hydrochlorothiazide Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Valsartan-Hydrochlorothiazide Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Valsartan-Hydrochlorothiazide Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Valsartan-Hydrochlorothiazide Sales Volume Share by Application (2021-2026) Table 35. Global Valsartan-Hydrochlorothiazide Sales Volume Share by Application (2027-2032) Table 36. Global Valsartan-Hydrochlorothiazide Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Valsartan-Hydrochlorothiazide Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Valsartan-Hydrochlorothiazide Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Valsartan-Hydrochlorothiazide Sales Value Share by Application (2021-2026) Table 40. Global Valsartan-Hydrochlorothiazide Sales Value Share by Application (2027-2032) Table 41. Global Valsartan-Hydrochlorothiazide Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Valsartan-Hydrochlorothiazide Sales by Region (2021-2026) & (K Units) Table 43. Global Valsartan-Hydrochlorothiazide Sales Market Share by Region (2021-2026) Table 44. Global Valsartan-Hydrochlorothiazide Sales by Region (2027-2032) & (K Units) Table 45. Global Valsartan-Hydrochlorothiazide Sales Market Share by Region (2027-2032) Table 46. Global Valsartan-Hydrochlorothiazide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Valsartan-Hydrochlorothiazide Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Valsartan-Hydrochlorothiazide Sales Value Share by Region (2021-2026) Table 49. Global Valsartan-Hydrochlorothiazide Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Valsartan-Hydrochlorothiazide Sales Value Share by Region (2027-2032) Table 51. Global Valsartan-Hydrochlorothiazide Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Valsartan-Hydrochlorothiazide Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Valsartan-Hydrochlorothiazide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Valsartan-Hydrochlorothiazide Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Valsartan-Hydrochlorothiazide Sales by Country (2021-2026) & (K Units) Table 56. Global Valsartan-Hydrochlorothiazide Sales Market Share by Country (2021-2026) Table 57. Global Valsartan-Hydrochlorothiazide Sales by Country (2027-2032) & (K Units) Table 58. Global Valsartan-Hydrochlorothiazide Sales Market Share by Country (2027-2032) Table 59. Global Valsartan-Hydrochlorothiazide Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Valsartan-Hydrochlorothiazide Sales Value Market Share by Country (2021-2026) Table 61. Global Valsartan-Hydrochlorothiazide Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Valsartan-Hydrochlorothiazide Sales Value Market Share by Country (2027-2032) Table 63. Teva Company Information Table 64. Teva Business Overview Table 65. Teva Valsartan-Hydrochlorothiazide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Teva Valsartan-Hydrochlorothiazide Product Portfolio Table 67. Teva Recent Development Table 68. Novartis Company Information Table 69. Novartis Business Overview Table 70. Novartis Valsartan-Hydrochlorothiazide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Novartis Valsartan-Hydrochlorothiazide Product Portfolio Table 72. Novartis Recent Development Table 73. Mylan Company Information Table 74. Mylan Business Overview Table 75. Mylan Valsartan-Hydrochlorothiazide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Mylan Valsartan-Hydrochlorothiazide Product Portfolio Table 77. Mylan Recent Development Table 78. Huaren Pharmaceutical Company Information Table 79. Huaren Pharmaceutical Business Overview Table 80. Huaren Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Huaren Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio Table 82. Huaren Pharmaceutical Recent Development Table 83. Zhejiang Huahai Pharmaceutical Company Information Table 84. Zhejiang Huahai Pharmaceutical Business Overview Table 85. Zhejiang Huahai Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Zhejiang Huahai Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio Table 87. Zhejiang Huahai Pharmaceutical Recent Development Table 88. Torrent Pharmaceuticals Company Information Table 89. Torrent Pharmaceuticals Business Overview Table 90. Torrent Pharmaceuticals Valsartan-Hydrochlorothiazide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Torrent Pharmaceuticals Valsartan-Hydrochlorothiazide Product Portfolio Table 92. Torrent Pharmaceuticals Recent Development Table 93. Par Pharmaceutical Company Information Table 94. Par Pharmaceutical Business Overview Table 95. Par Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Par Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio Table 97. Par Pharmaceutical Recent Development Table 98. MACLEODS Company Information Table 99. MACLEODS Business Overview Table 100. MACLEODS Valsartan-Hydrochlorothiazide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. MACLEODS Valsartan-Hydrochlorothiazide Product Portfolio Table 102. MACLEODS Recent Development Table 103. Lupin Company Information Table 104. Lupin Business Overview Table 105. Lupin Valsartan-Hydrochlorothiazide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Lupin Valsartan-Hydrochlorothiazide Product Portfolio Table 107. Lupin Recent Development Table 108. Cisen Pharmaceutical Company Information Table 109. Cisen Pharmaceutical Business Overview Table 110. Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio Table 112. Cisen Pharmaceutical Recent Development Table 113. Chongqing Conquer Pharmaceutical Company Information Table 114. Chongqing Conquer Pharmaceutical Business Overview Table 115. Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio Table 117. Chongqing Conquer Pharmaceutical Recent Development Table 118. Beijing Second Pharmaceutical Company Information Table 119. Beijing Second Pharmaceutical Business Overview Table 120. Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio Table 122. Beijing Second Pharmaceutical Recent Development Table 123. Aurobindo Pharma Company Information Table 124. Aurobindo Pharma Business Overview Table 125. Aurobindo Pharma Valsartan-Hydrochlorothiazide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Aurobindo Pharma Valsartan-Hydrochlorothiazide Product Portfolio Table 127. Aurobindo Pharma Recent Development Table 128. APOTEX Company Information Table 129. APOTEX Business Overview Table 130. APOTEX Valsartan-Hydrochlorothiazide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. APOTEX Valsartan-Hydrochlorothiazide Product Portfolio Table 132. APOTEX Recent Development Table 133. Alembic Pharmaceuticals Company Information Table 134. Alembic Pharmaceuticals Business Overview Table 135. Alembic Pharmaceuticals Valsartan-Hydrochlorothiazide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Alembic Pharmaceuticals Valsartan-Hydrochlorothiazide Product Portfolio Table 137. Alembic Pharmaceuticals Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Valsartan-Hydrochlorothiazide Distributors List Table 141. Valsartan-Hydrochlorothiazide Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Valsartan-Hydrochlorothiazide Product Image Figure 2. Global Valsartan-Hydrochlorothiazide Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Valsartan-Hydrochlorothiazide Sales Value (2021-2032) & (US$ Million) Figure 4. Global Valsartan-Hydrochlorothiazide Sales (2021-2032) & (K Units) Figure 5. Global Valsartan-Hydrochlorothiazide Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Valsartan-Hydrochlorothiazide Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablet Image Figure 10. Capsule Image Figure 11. Global Valsartan-Hydrochlorothiazide Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Valsartan-Hydrochlorothiazide Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Valsartan-Hydrochlorothiazide Sales Volume Share by Type (2021-2032) Figure 14. Global Valsartan-Hydrochlorothiazide Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Valsartan-Hydrochlorothiazide Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Valsartan-Hydrochlorothiazide Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Drug Store Image Figure 19. Global Valsartan-Hydrochlorothiazide Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Valsartan-Hydrochlorothiazide Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Valsartan-Hydrochlorothiazide Sales Volume Share by Application (2021-2032) Figure 22. Global Valsartan-Hydrochlorothiazide Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Valsartan-Hydrochlorothiazide Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Valsartan-Hydrochlorothiazide Sales Value Share by Application (2021-2032) Figure 25. Global Valsartan-Hydrochlorothiazide Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Valsartan-Hydrochlorothiazide Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Valsartan-Hydrochlorothiazide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Valsartan-Hydrochlorothiazide Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Valsartan-Hydrochlorothiazide Sales Value (2021-2032) & (US$ Million) Figure 30. North America Valsartan-Hydrochlorothiazide Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Valsartan-Hydrochlorothiazide Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Valsartan-Hydrochlorothiazide Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Valsartan-Hydrochlorothiazide Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Valsartan-Hydrochlorothiazide Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Valsartan-Hydrochlorothiazide Sales Value (2021-2032) & (US$ Million) Figure 36. South America Valsartan-Hydrochlorothiazide Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Valsartan-Hydrochlorothiazide Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Valsartan-Hydrochlorothiazide Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Valsartan-Hydrochlorothiazide Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Valsartan-Hydrochlorothiazide Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Capsule
Applications
  • Hospital
  • Drug Store
Companies covered
  • Teva
  • Novartis
  • Mylan
  • Huaren Pharmaceutical
  • Zhejiang Huahai Pharmaceutical
  • Torrent Pharmaceuticals
  • Par Pharmaceutical
  • MACLEODS
  • Lupin
  • Cisen Pharmaceutical
  • Chongqing Conquer Pharmaceutical
  • Beijing Second Pharmaceutical
  • Aurobindo Pharma
  • APOTEX
  • Alembic Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Valsartan-Hydrochlorothiazide Sales Value (2021-2032)
  4. 1.2.2 Global Valsartan-Hydrochlorothiazide Sales Volume (2021-2032)
  5. 1.2.3 Global Valsartan-Hydrochlorothiazide Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Valsartan-Hydrochlorothiazide Market Dynamics
  1. 2.1 Valsartan-Hydrochlorothiazide Industry Trends
  2. 2.2 Valsartan-Hydrochlorothiazide Industry Drivers
  3. 2.3 Valsartan-Hydrochlorothiazide Industry Opportunities and Challenges
  4. 2.4 Valsartan-Hydrochlorothiazide Industry Restraints
3 Valsartan-Hydrochlorothiazide Market by Company
  1. 3.1 Global Valsartan-Hydrochlorothiazide Company Revenue Ranking in 2025
  2. 3.2 Global Valsartan-Hydrochlorothiazide Revenue by Company (2021-2026)
  3. 3.3 Global Valsartan-Hydrochlorothiazide Sales Volume by Company (2021-2026)
  4. 3.4 Global Valsartan-Hydrochlorothiazide Average Price by Company (2021-2026)
  5. 3.5 Global Valsartan-Hydrochlorothiazide Company Ranking (2024-2026)
  6. 3.6 Global Valsartan-Hydrochlorothiazide Company Manufacturing Base and Headquarters
  7. 3.7 Global Valsartan-Hydrochlorothiazide Company Product Type and Application
  8. 3.8 Global Valsartan-Hydrochlorothiazide Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Valsartan-Hydrochlorothiazide Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Valsartan-Hydrochlorothiazide Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Valsartan-Hydrochlorothiazide Market by Type
  1. 4.1 Valsartan-Hydrochlorothiazide Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Capsule
  4. 4.2 Global Valsartan-Hydrochlorothiazide Sales Volume by Type
  5. 4.2.1 Global Valsartan-Hydrochlorothiazide Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Valsartan-Hydrochlorothiazide Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Valsartan-Hydrochlorothiazide Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Valsartan-Hydrochlorothiazide Sales Value by Type
  9. 4.3.1 Global Valsartan-Hydrochlorothiazide Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Valsartan-Hydrochlorothiazide Sales Value by Type (2021-2032)
  11. 4.3.3 Global Valsartan-Hydrochlorothiazide Sales Value Share by Type (2021-2032)
5 Valsartan-Hydrochlorothiazide Market by Application
  1. 5.1 Valsartan-Hydrochlorothiazide Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Store
  4. 5.2 Global Valsartan-Hydrochlorothiazide Sales Volume by Application
  5. 5.2.1 Global Valsartan-Hydrochlorothiazide Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Valsartan-Hydrochlorothiazide Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Valsartan-Hydrochlorothiazide Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Valsartan-Hydrochlorothiazide Sales Value by Application
  9. 5.3.1 Global Valsartan-Hydrochlorothiazide Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Valsartan-Hydrochlorothiazide Sales Value by Application (2021-2032)
  11. 5.3.3 Global Valsartan-Hydrochlorothiazide Sales Value Share by Application (2021-2032)
6 Valsartan-Hydrochlorothiazide Regional Sales and Value Analysis
  1. 6.1 Global Valsartan-Hydrochlorothiazide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Valsartan-Hydrochlorothiazide Sales by Region (2021-2032)
  3. 6.2.1 Global Valsartan-Hydrochlorothiazide Sales by Region: 2021-2026
  4. 6.2.2 Global Valsartan-Hydrochlorothiazide Sales by Region (2027-2032)
  5. 6.3 Global Valsartan-Hydrochlorothiazide Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Valsartan-Hydrochlorothiazide Sales Value by Region (2021-2032)
  7. 6.4.1 Global Valsartan-Hydrochlorothiazide Sales Value by Region: 2021-2026
  8. 6.4.2 Global Valsartan-Hydrochlorothiazide Sales Value by Region (2027-2032)
  9. 6.5 Global Valsartan-Hydrochlorothiazide Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Valsartan-Hydrochlorothiazide Sales Value (2021-2032)
  12. 6.6.2 North America Valsartan-Hydrochlorothiazide Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Valsartan-Hydrochlorothiazide Sales Value (2021-2032)
  15. 6.7.2 Europe Valsartan-Hydrochlorothiazide Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Valsartan-Hydrochlorothiazide Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Valsartan-Hydrochlorothiazide Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Valsartan-Hydrochlorothiazide Sales Value (2021-2032)
  21. 6.9.2 South America Valsartan-Hydrochlorothiazide Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Valsartan-Hydrochlorothiazide Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Valsartan-Hydrochlorothiazide Sales Value Share by Country, 2025 VS 2032
7 Valsartan-Hydrochlorothiazide Country-level Sales and Value Analysis
  1. 7.1 Global Valsartan-Hydrochlorothiazide Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Valsartan-Hydrochlorothiazide Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Valsartan-Hydrochlorothiazide Sales by Country (2021-2032)
  4. 7.3.1 Global Valsartan-Hydrochlorothiazide Sales by Country (2021-2026)
  5. 7.3.2 Global Valsartan-Hydrochlorothiazide Sales by Country (2027-2032)
  6. 7.4 Global Valsartan-Hydrochlorothiazide Sales Value by Country (2021-2032)
  7. 7.4.1 Global Valsartan-Hydrochlorothiazide Sales Value by Country (2021-2026)
  8. 7.4.2 Global Valsartan-Hydrochlorothiazide Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Valsartan-Hydrochlorothiazide Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Valsartan-Hydrochlorothiazide Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Valsartan-Hydrochlorothiazide Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Valsartan-Hydrochlorothiazide Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Valsartan-Hydrochlorothiazide Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Valsartan-Hydrochlorothiazide Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Valsartan-Hydrochlorothiazide Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Valsartan-Hydrochlorothiazide Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Valsartan-Hydrochlorothiazide Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 Huaren Pharmaceutical
  20. 8.4.1 Huaren Pharmaceutical Company Information
  21. 8.4.2 Huaren Pharmaceutical Business Overview
  22. 8.4.3 Huaren Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Huaren Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
  24. 8.4.5 Huaren Pharmaceutical Recent Developments
  25. 8.5 Zhejiang Huahai Pharmaceutical
  26. 8.5.1 Zhejiang Huahai Pharmaceutical Company Information
  27. 8.5.2 Zhejiang Huahai Pharmaceutical Business Overview
  28. 8.5.3 Zhejiang Huahai Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Zhejiang Huahai Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
  30. 8.5.5 Zhejiang Huahai Pharmaceutical Recent Developments
  31. 8.6 Torrent Pharmaceuticals
  32. 8.6.1 Torrent Pharmaceuticals Company Information
  33. 8.6.2 Torrent Pharmaceuticals Business Overview
  34. 8.6.3 Torrent Pharmaceuticals Valsartan-Hydrochlorothiazide Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Torrent Pharmaceuticals Valsartan-Hydrochlorothiazide Product Portfolio
  36. 8.6.5 Torrent Pharmaceuticals Recent Developments
  37. 8.7 Par Pharmaceutical
  38. 8.7.1 Par Pharmaceutical Company Information
  39. 8.7.2 Par Pharmaceutical Business Overview
  40. 8.7.3 Par Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Par Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
  42. 8.7.5 Par Pharmaceutical Recent Developments
  43. 8.8 MACLEODS
  44. 8.8.1 MACLEODS Company Information
  45. 8.8.2 MACLEODS Business Overview
  46. 8.8.3 MACLEODS Valsartan-Hydrochlorothiazide Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 MACLEODS Valsartan-Hydrochlorothiazide Product Portfolio
  48. 8.8.5 MACLEODS Recent Developments
  49. 8.9 Lupin
  50. 8.9.1 Lupin Company Information
  51. 8.9.2 Lupin Business Overview
  52. 8.9.3 Lupin Valsartan-Hydrochlorothiazide Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Lupin Valsartan-Hydrochlorothiazide Product Portfolio
  54. 8.9.5 Lupin Recent Developments
  55. 8.10 Cisen Pharmaceutical
  56. 8.10.1 Cisen Pharmaceutical Company Information
  57. 8.10.2 Cisen Pharmaceutical Business Overview
  58. 8.10.3 Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
  60. 8.10.5 Cisen Pharmaceutical Recent Developments
  61. 8.11 Chongqing Conquer Pharmaceutical
  62. 8.11.1 Chongqing Conquer Pharmaceutical Company Information
  63. 8.11.2 Chongqing Conquer Pharmaceutical Business Overview
  64. 8.11.3 Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
  66. 8.11.5 Chongqing Conquer Pharmaceutical Recent Developments
  67. 8.12 Beijing Second Pharmaceutical
  68. 8.12.1 Beijing Second Pharmaceutical Company Information
  69. 8.12.2 Beijing Second Pharmaceutical Business Overview
  70. 8.12.3 Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
  72. 8.12.5 Beijing Second Pharmaceutical Recent Developments
  73. 8.13 Aurobindo Pharma
  74. 8.13.1 Aurobindo Pharma Company Information
  75. 8.13.2 Aurobindo Pharma Business Overview
  76. 8.13.3 Aurobindo Pharma Valsartan-Hydrochlorothiazide Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Aurobindo Pharma Valsartan-Hydrochlorothiazide Product Portfolio
  78. 8.13.5 Aurobindo Pharma Recent Developments
  79. 8.14 APOTEX
  80. 8.14.1 APOTEX Company Information
  81. 8.14.2 APOTEX Business Overview
  82. 8.14.3 APOTEX Valsartan-Hydrochlorothiazide Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 APOTEX Valsartan-Hydrochlorothiazide Product Portfolio
  84. 8.14.5 APOTEX Recent Developments
  85. 8.15 Alembic Pharmaceuticals
  86. 8.15.1 Alembic Pharmaceuticals Company Information
  87. 8.15.2 Alembic Pharmaceuticals Business Overview
  88. 8.15.3 Alembic Pharmaceuticals Valsartan-Hydrochlorothiazide Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Alembic Pharmaceuticals Valsartan-Hydrochlorothiazide Product Portfolio
  90. 8.15.5 Alembic Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Valsartan-Hydrochlorothiazide Value Chain Analysis
  2. 9.1.1 Valsartan-Hydrochlorothiazide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Valsartan-Hydrochlorothiazide Sales Mode & Process
  6. 9.2 Valsartan-Hydrochlorothiazide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Valsartan-Hydrochlorothiazide Distributors
  9. 9.2.3 Valsartan-Hydrochlorothiazide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst